rs114838832
|
MUCL3;SFTA2
|
Schizophrenia
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
|
28540026 |
2017 |
rs114838832
|
MUCL3;SFTA2
|
Child Development Disorders, Pervasive
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
|
28540026 |
2017 |
rs115123027
|
MUCL3;SFTA2
|
Schizophrenia
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
|
30285260 |
2019 |
rs12697941
|
MUCL3;SFTA2
|
AIDS, PROGRESSION TO
|
|
0.700 |
GeneticVariation |
GWASDB |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
rs12697941
|
MUCL3;SFTA2
|
HIV-1, RESISTANCE TO
|
|
0.700 |
GeneticVariation |
GWASDB |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
rs12697941
|
MUCL3;SFTA2
|
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
|
0.700 |
GeneticVariation |
GWASDB |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
rs12697941
|
MUCL3;SFTA2
|
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
|
0.700 |
GeneticVariation |
GWASDB |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
rs3132571
|
MUCL3;SFTA2
|
Diabetes Mellitus, Insulin-Dependent
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.
|
17632545 |
2007 |
rs3132571
|
MUCL3;SFTA2
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.
|
19503088 |
2009 |
rs6933400
|
MUCL3;SFTA2
|
Coronary heart disease
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study of coronary artery disease in the Japanese.
|
21971053 |
2012 |
rs3132581
|
MUCL3;SFTA2;HCG21
|
Attention deficit hyperactivity disorder
|
G |
0.800 |
GeneticVariation |
GWASDB |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
rs3132581
|
MUCL3;SFTA2;HCG21
|
Attention deficit hyperactivity disorder
|
G |
0.800 |
GeneticVariation |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
rs12190030
|
MUCL3;SFTA2;HCG21
|
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
|
0.700 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs12190030
|
MUCL3;SFTA2;HCG21
|
HIV-1, RESISTANCE TO
|
|
0.700 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs12190030
|
MUCL3;SFTA2;HCG21
|
AIDS, PROGRESSION TO
|
|
0.700 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs12190030
|
MUCL3;SFTA2;HCG21
|
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
|
0.700 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs2240804
|
MUCL3;SFTA2;HCG21
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.
|
17804836 |
2007 |
rs2240804
|
MUCL3;SFTA2;HCG21
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.
|
19503088 |
2009 |
rs3132580
|
MUCL3;SFTA2;HCG21
|
Malignant neoplasm of lung
|
|
0.700 |
GeneticVariation |
GWASDB |
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.
|
22899653 |
2012 |
rs3132580
|
MUCL3;SFTA2;HCG21
|
Diabetes Mellitus, Insulin-Dependent
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.
|
17632545 |
2007 |
rs3132580
|
MUCL3;SFTA2;HCG21
|
Membranous glomerulonephritis
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.
|
21323541 |
2011 |
rs3132580
|
MUCL3;SFTA2;HCG21
|
Lupus Erythematosus, Systemic
|
A |
0.700 |
GeneticVariation |
GWASDB |
GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region.
|
24871463 |
2014 |
rs3132580
|
MUCL3;SFTA2;HCG21
|
Adenocarcinoma of lung (disorder)
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.
|
19836008 |
2009 |
rs3132580
|
MUCL3;SFTA2;HCG21
|
Myasthenia Gravis
|
|
0.700 |
GeneticVariation |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
rs3132580
|
MUCL3;SFTA2;HCG21
|
Vitiligo
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.
|
20526339 |
2010 |